COLLABORATIVE PRESCRIBING OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR EMERGENT ANTICOAGULATION REVERSAL

Authors :: Kenneth K. Tran
Andrew J. Franck
Andrew L. Hendrickson
Evan D. Telford
Source :: Journal of the American College of Cardiology. 73:2136
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.
Abstract: Emergent reversal of oral anticoagulation (OAC), including vitamin K antagonist (VKA) and direct-acting oral anticoagulant (DOAC) therapy, continues to be an important aspect of OAC due to the potential for serious bleeding events. Four-factor prothrombin complex concentrate (4F-PCC) is commonly

Subjects :: medicine.medical_specialty
medicine.drug_class
business.industry
Anticoagulation Reversal
Vitamin K antagonist
Gastroenterology
Prothrombin complex concentrate
Internal medicine
Oral anticoagulant
medicine
Cardiology and Cardiovascular Medicine
business
Oral anticoagulation
medicine.drug

Full Text Access

Tools